Implantable medical devices such as pacemakers and insulin pumps usually work in isolation, and the radio systems they use to communicate are a poor fit for the body. Bluetooth and near-field communication are heavily weakened by tissue, need relatively large antennas, and can drain an implant's battery by up to 90 percent when active. Researchers at Georgia Tech have built a system called SWANS that instead uses the body's own tissue as a signaling medium, mimicking the way neurons use ions to transmit messages.
The commercial appeal is clear: the implants are small enough to be injected with a syringe, draw almost no power while listening, and can be coordinated by a wearable hub that handles the heavy processing. In tests with live rats, the system sent signals from a hub on the stomach to implants in the back, and even triggered leg twitches by stimulating the sciatic nerve. The team also demonstrated an implant-to-implant relay that passed a signal only when a temperature sensor registered a fever, showing how networked devices could respond to changing conditions.
Still, the technology is not ready for the market. Voltage thresholds must be tuned for each body and implant placement, and scar tissue that formed around implants in a two-month rat study required raising voltage within safe limits. The researchers note that pacemakers and neurostimulators already use similar voltages and pulse lengths, and an FDA-cleared pill called Abilify MyCite has shown that ionic conduction can work in approved products—but that system only links two devices. SWANS aims to connect many, which could open the door to more coordinated implantable therapies if further safety and reliability testing succeeds.